RxDoctor Payments Data

Milagros Montalvo Rosa, MD

General Practice · Keystone Heights, FLNPI 1528262011

Payments from drug & device makers

$688in general payments, 2019–2025

Across 34 payments — averaging $20.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$266
  • GSK$110
  • Exact Sciences$80
  • Lilly USA, LLC$73
  • Amgen$49
  • Insulet Corporation$38
  • plus $71 from 4 others

What the payments were for

  • Food & beverage$688100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$688 in reported general payments places this provider in the 70th percentile of 6,901 general practice providers in Florida.

See all general practice providers in Florida

Medicare billing

Part B allowed, 2024
$535
Medicare patients
33
Services billed
63

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban74$72,475
TrulicityDulaglutide60$57,814
Trelegy ElliptaFluticasone/Umeclidin/Vilanter70$54,575
JanuviaSitagliptin Phosphate24$41,287
JardianceEmpagliflozin43$37,570
XareltoRivaroxaban24$29,299
Humulin R U-500Insulin Regular, Human14$20,972
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog13$17,069
JanumetSitagliptin Phos/Metformin Hcl16$13,190
FarxigaDapagliflozin Propanediol12$10,189
VascepaIcosapent Ethyl23$9,705
Janumet XrSitagliptin Phos/Metformin Hcl11$6,056
Advair DiskusFluticasone Propion/Salmeterol17$3,186
Lantus SolostarInsulin Glargine,hum.Rec.Anlog35$2,888
Rosuvastatin Calcium235$2,554

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$14$72,47574 claims
Lilly USA, LLCTrulicity$73$57,81460 claims
GSKTrelegy Ellipta$110$54,57570 claims
AstraZenecaFarxiga$17$10,18912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 6,901 general practice providers in Florida.

Other general practice in Keystone Heights

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →